Holen Sie sich die Stockscreener-App
6.93
3.88%
-0.28
Handel nachbörslich:
6.90
-0.03
-0.43%
Schlusskurs vom Vortag:
$7.21
Offen:
$7.17
24-Stunden-Volumen:
259.99K
Relative Volume:
0.74
Marktkapitalisierung:
$225.88M
Einnahmen:
$124.00K
Nettoeinkommen (Verlust:
$-37.94M
KGV:
-6.2432
EPS:
-1.11
Netto-Cashflow:
$-34.70M
1W Leistung:
-0.14%
1M Leistung:
+2.67%
6M Leistung:
+338.61%
1J Leistung:
+653.26%
1-Tages-Spanne:
$6.76
$7.41
1-Wochen-Bereich:
$6.76
$7.41
52-Wochen-Spanne:
$0.66
$14.30
Candel Therapeutics Inc Stock (CADL) Company Profile
Firmenname
Candel Therapeutics Inc
Sektor
Branche
Telefon
617-916-5445
Adresse
117 KENDRICK STREET, NEEDHAM
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-08-23 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-23 | Eingeleitet | Jefferies | Buy |
| 2021-08-23 | Eingeleitet | UBS | Buy |
Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten
Citigroup Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - Defense World
Citi raises Cogent price target on bezuclastinib potential - Investing.com India
Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios - The Dwinnex
(CADL) Proactive Strategies - Stock Traders Daily
Gaining Ground: Cogent Biosciences Inc (COGT) Closes Lower at 10.65, Down -3.01 - The Dwinnex
Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily
Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel - MarketWatch
Cintas Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Kayne Anderson Rudnick Investment Management LLC Trims Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Cadence Design Systems Inc. stock rises Monday, still underperforms market - MarketWatch
Xponance Inc. Has $24.15 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Hood River Capital Management LLC Has $13.71 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha
Is it possible to buy Candel Therapeutics Inc(CADL) shares at a good price now? - US Post News
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Kayne Anderson Rudnick Investment Management LLC Trims Stake in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St
Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat
Sands Capital Ventures LLC Cuts Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World
Sands Capital Ventures LLC Trims Stock Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - MarketBeat
Davidson Capital Management Inc. Buys 11,978 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Did Candel Therapeutics Inc (CADL) perform well in the last session? - US Post News
Corbus drops after rival Novo Nordisk reports obesity drug data - XM
Choreo LLC Purchases Shares of 23,033 Coty Inc. (NYSE:COTY) - Defense World
Cadence design systems director sells $414k in company stock - Investing.com
Sienna Gestion Trims Stake in Copart, Inc. (NASDAQ:CPRT) - Defense World
Catalyst Pharmaceuticals stock hits 52-week high at $20.88 - Investing.com
Cibus price target lowered to $20 from $21 at Canaccord - TipRanks
Why Casella Waste Systems (CWST) Stock Is Falling - Benzinga
Why Cibus (CBUS) Stock Is Down 21% Wednesday - Benzinga
Cibus Shares Fall on Plan to Raise $12 Million in Offering - MarketWatch
Cadence Stock Down 16% in 3 Months: Should You Buy, Sell or Hold? - Nasdaq
Cibus sets price for 3 million share public offering - Investing.com
Retail investors who hold 48% of Candel Therapeutics, Inc. (NASDAQ:CADL) gained 14%, insiders profited as well - Simply Wall St
Learn to Evaluate (CADL) using the Charts - Stock Traders Daily
Candel Therapeutics, Inc. (NASDAQ:CADL) most popular amongst individual investors who own 48%, insiders hold 30% - Yahoo Finance
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewswire Inc.
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Candel Therapeutics Inc (CADL) Stock: A Year of Decreases and Increases - The InvestChronicle
Candel Therapeutics, Inc. (NASDAQ:CADL) Sees Significant Increase in Short Interest - MarketBeat
Where are the Opportunities in (CADL) - Stock Traders Daily
Candel Therapeutics, Inc. (NASDAQ:CADL) Sees Significant Growth in Short Interest - Defense World
Candel Therapeutics, Inc. (NASDAQ:CADL) Short Interest Up 5.7% in July - MarketBeat
CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024 - InvestorPlace
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - citybiz
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - wallstreet:online
Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):